UBS Stands Behind Berkshire Hathaway With Buy Rating, Trims Price Target to $570

May 6, 2026

By TrendSpider Editor

UBS Stands Behind Berkshire Hathaway With Buy Rating, Trims Price Target to $570

UBS analyst Brian Meredith reaffirmed a buy rating on Berkshire Hathaway Inc. (BRK.B) on Wednesday while trimming his price target from $581 to $570, signaling continued conviction in the conglomerate but acknowledging some near-term headwinds. BRK.B currently trades at $469.93, up 0.95% on the session, yet remains under pressure near the lower end of its 52-week range of $455.19 to $521.26. The $570 price target implies meaningful upside from current levels, even after the modest target reduction.

Key Drivers of the BRK.B Stock Move

Main Catalyst: UBS analyst Brian Meredith confirmed a buy rating on BRK.B while cutting his price target from $581 to $570, a reduction of $11. The confirmation of the buy stance despite the trim suggests the thesis remains intact, though the analyst sees a slightly lower ceiling for the stock in the near term.
Bull Case: The $570 price target still represents approximately 21% upside from the current price of $469.93. A maintained buy rating from a major Wall Street firm provides a vote of confidence at a time when the stock is trading close to its 52-week low of $455.19, potentially offering an attractive entry point for longer-term investors.
Bear Case: The price target cut from $581 to $570 indicates that UBS sees reduced upside compared to its prior view. With BRK.B near its 52-week low and the target moving lower, the revision raises questions about whether further adjustments could follow if macro or business conditions deteriorate, leaving the stock vulnerable to additional downside toward the $455.19 floor.

The forward setup for BRK.B is nuanced. The stock is hovering uncomfortably close to its 52-week low, and while UBS is not abandoning its bullish stance, the lower price target is a signal that expectations have been tempered. Berkshire Hathaway's diversified business model, encompassing insurance, energy, manufacturing, and a substantial equity portfolio, gives it a degree of resilience that most companies lack, but it is not immune to macroeconomic pressures weighing on valuations across financial and industrial sectors in 2026. The UBS confirmation could help stabilize sentiment around the stock near current levels, though a catalyst for a meaningful rebound above the midpoint of its 52-week range would likely require either a strong earnings report or a broader market recovery.

BRK.B Analyst Ratings and Price Targets

UBS analyst Brian Meredith confirmed a buy rating on BRK.B on May 6, 2026, with a revised price target of $570, down from a prior target of $581. There were no upgrades or downgrades associated with this action. The average price target based on available analyst data stands at $570.

BRK.B Seasonality

May has historically been a transitional month for large-cap financial and conglomerate stocks following first-quarter earnings season, with analyst rating actions often clustering in the first two weeks as firms digest results and adjust models. A buy confirmation in early May may reflect an analyst reaffirming their view in the wake of quarterly reporting rather than a response to new fundamental developments.

BRK.B Relative Performance

BRK.B's current price of $469.93 places it near the lower boundary of its 52-week range of $455.19 to $521.26, indicating the stock has experienced considerable distance from its annual highs. The 0.95% gain on the session offers modest relief, but the broader trend reflected in the stock's proximity to its 52-week low suggests BRK.B has underperformed relative to where it stood at stronger points over the past year. Investors will be watching whether the UBS confirmation, combined with the stock's positioning near technical support, can help build a base for a move back toward the upper portion of the range.